Estrogen replacement therapy (ERT) is a pharmaceutical intervention directly designed to impact bone remodeling based on the association between estrogen decline and osteoporosis after menopause. Hormone replacement therapy (HRT) augments estrogen with progestogens. These treatments have different and controversial risks associated with breast cancer, coronary heart disease, and stroke that impact their adoption based on individualized management of benefits and risks .